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Oxygen desaturation during sleep and exercise in 
patients with severe chronic obstructive pulmonary 
disease 
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Department of Respiratory Medicine and the Respiratory Sleep Laboratory, St Vincent’s Hospital, 
Dublin, Ireland 
Patients with chronic obstructive pulmonary disease (COPD) have varying degrees of arterial oxyhaemoglobin 
desaturation during sleep, which have been shown to correlate with awake oxygen levels. We wished to 
ascertain if exercise desaturation was a better predictor of nocturnal oxygen desaturation than daytime blood 
gases. We studied 25 COPD patients with PaO, ~10 kPa (mean=8.6 kPa), 12 of whom were normocapnic 
(PaCO, 16 kPa, Group A), and 13 of whom were hypercapnic (PaCO, ~6 kPa, Group B), by means of 
overnight oximetry and maximum treadmill exercise testing. The overall group desaturated significantly more 
during sleep than exercise [12.9 f 10.5 fall in nocturnal oxygen saturation (SaO,) vs. 4.5 f 3.7, P<O.Ol]. Group 
B had a lower minimum SaO, during sleep than Group A (74.3 % 13.4 vs. 84.6 & 5.8, P<O.O5), despite very 
similar pre-sleep SaO, (91.9 f 3.2 vs. 92.8 f 2.9, P=n.s.). Awake SaO, correlated well with both mean values 
(r=0.7, P<O.OOl), and minimum sleep SaO, (r=044, P<O.O5), but not with the fall in sleep SaO, (r=0.21, 
P=n.s.). Minimum sleep and exercise SaO, were also significantly correlated (r=0.44, P~0.05) but the fall in 
SaO, during sleep and exercise was not (P=n.s.). We conclude that exercise studies add no extra information 
to awake blood gas analysis in predicting the likelihood of nocturnal oxygen desaturation in patients with 
COPD. 
Introduction 
Oxygen desaturation is known to occur during 
sleep in patients with chronic obstructive pulmonary 
disease (COPD), particularly during rapid eye move- 
ment (REM) sleep (l-5). This desaturation may 
predispose to nocturnal death (6), and may also 
contribute to the development of pulmonary hyper- 
tension (7). Awake arterial oxygen tension (PaO,) 
correlates with nocturnal oxygen saturation (SaO,) 
(4,8,9,10), but recent studies have also documented 
significant oxygen desaturation in patients with only 
mild daytime hypoxaemia (5). Exercise may also lead 
to hypoxaemia in patients with COPD (11,12), and 
while a previous study has examined haemodynamic 
variables during sleep and exercise in COPD (13), 
there are no published studies examining potential 
relationships between oxygen desaturation during 
sleep and exercise in such patients. 
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The mechanisms leading to oxygen desaturation 
are likely to differ during sleep and exercise, with 
hypoventilation and changes in ventilation-perfusion 
relationships being important mechanisms during 
sleep (1,4,14,15,16), whereas increased airflow 
resistance and inadequate ventilatory response to 
exercise, in addition to dead space ventilation are 
important factors during exercise (11,17,18). How- 
ever, we hypothesised that patients with severe 
COPD would desaturate during both exercise and 
sleep, and therefore, that exercise-related desatura- 
tion might provide a useful insight into the likelihood 
of nocturnal desaturation. 
The purpose of the present study was to com- 
pare oxygen desaturation during sleep and exercise 
in patients with severe COPD. We sought relation- 
ships between SaO, values during sleep and 
exercise, in addition to awake blood gases, and 
pulmonary function. We wished to determine if 
a knowledge of the degree of exercise-related 
desaturation might improve the ability to predict 
a likelihood of nocturnal desaturation in these 
patients. 
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Materials and Methods 
Thirty patients with an established diagnosis of 
COPD, and fulfilling the entry criteria were studied. 
All were hospital inpatients convalescing from a 
recent non-pneumonic episode of respiratory failure 
(PaO, ~8 kPa). They were studied when they were in 
a stable condition immediately prior to hospital 
discharge. At the time of the study, each patient had 
PaO, less than 10 kPa, forced expiratory volume in 
1 s (FEV,) less than 1.5 1 and FEV,/forced vital 
capacity (FVC) less than 60%. Informed consent was 
obtained from all patients and the study was 
approved by the hospital’s Ethics Committee. All 
patients were on bronchodilator treatment, which 
consisted of both oral and inhaled corticosteroids, 
oral theophylline, and inhaled or nebulized P-agonist 
and anti-cholinergic. No patient was on oral 
P-agonist therapy and no inhaled P-agonist or anti- 
cholinergic agent was taken for at least 6 h prior to 
either the sleep or exercise study. 
SLEEP STUDIES 
SaO, was measured continuously during sleep and 
exercise using a Biox 11A ear oximeter (Biox Inc., 
Boulder, CO), and recorded in real time on a Biox 
2100 paper recorder. The accuracy of this oximeter 
has been well validated (19), and all patients in the 
present study were white. Baseline or pre-sleep SaO, 
was taken as the mean SaO, for the first 20 min after 
the start of monitoring, while the patients were 
awake and supine. Mean nocturnal SaO, was taken 
as the mean SaO, from lights-out to final morning 
awakening, averaged at 2 min intervals. The mini- 
mum nocturnal SaO, that was maintained for at least 
30 s was noted, and this value was subtracted from 
the pre-sleep SaO, to give the maximum fall in 
nocturnal SaO,. The patients were observed by medi- 
cal and nursing personnel to assess sleep quality, and 
they were well acclimatized to the hospital environ- 
ment by the time of the study. Only data from nights 
where the sleep was judged to be good by both 
the patient and observer was utilized. Patients with 
features suggestive of sleep apnoea, such as a history 
of loud snoring or daytime sleepiness, or repetitive 
dips in their SaO, tracing, were excluded. 
EXERCISE TESTING 
The exercise test was performed on the afternoon 
after the sleep study. Blood gases (ABGs) were drawn 
from the radial artery and spirometry performed 
immediately before the exercise test. An incremental 
treadmill exercise test was utilized, following the 
modified Naughton protocol (20) which allows for a 
gradual increase in exercise intensity, suitable for 
patients with respiratory impairment. Exercise com- 
menced at a zero gradient and treadmill speed of 
1 mile h - ’ for 2 min. The work load was increased 
every 2 min with a progressive increase in speed and 
degree of elevation to a potential maximum of 3 mile 
h ~ ’ at 1.5 degrees elevation over 20 min. The patients 
were encouraged to exercise to exhaustion. SaO, and 
heart rate were continuously monitored during 
exercise. The pre-exercise SaO, was taken as the 
stable SaO, reading immediately prior to exercise. 
The minimum exercise SaO, was taken as the lowest 
SaO, reached, and where SaO, rose during exercise 
the highest level reached was noted. The difference 
between the pre-exercise SaO, and the lowest exercise 
SaO, (or highest) was taken as the fall (or rise) in 
exercise SaO,. 
STATISTICAL ANALYSIS 
The relationships between continuous variables 
were analysed by linear regression, and the indepen- 
dent t-test was used to compare means where there 
were two independent samples of continuous data. 
The Chi-Squared or Fisher’s Exact test were used 
to compare proportions of categorical data. A sig- 
nificance level of less than 0.05 was taken as signifi- 
cant, and data are presented as mean & 1 standard 
deviation (SD). 
Results 
The data for 25 patients were included in the 
analysis (16 males, 9 females). Five patients were 
excluded from the analysis because of unsatisfactory 
sleep quality, or the presence of artefacts or tracings 
suggestive of an associated sleep apnoea (repetitive 
transient SaO, dips) on their overnight SaO, trac- 
ings. Anthropometric, spirometric and blood gas 
data for the 25 included patients are presented in 
Table 1, which also provides details of changes in 
SaO, during sleep and exercise, among hypercapnic 
and normocapnic patients. 
There was a wide variability in the maximum 
degree of overnight desaturation (range 3-52% fall in 
SaO, from baseline). However, most of these steep 
falls in SaO, were relatively brief, and the mean 
nocturnal SaO, was 91% (range 78-95%). These data 
indicate a relatively mild degree of oxygen desatura- 
tion during sleep in this group of patients. In fact, 
nine patients had a mean nocturnal SaO, the same or 
slightly higher than their pre-sleep SaO,. 
There was, however, a substantially greater fall in 
SaO, during sleep than exercise [12.9(10.5) VS. 
4.5(3.7)%, P<O.Ol]. While the duration of exercise 
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Table I Anthropometric data, blood gases, pulmonary function, sleep and exercise SaO,, 
comparing patients with normocapnia (n= 12) and hypercapnia (PaCO, >6 kPa; n= 13) 
All patients Normocapnic Hypercapnic P value* 
Age W 
BMI (kg mm’) 
Pulmonary function 
FEV, (% predicted) 
FEVJFVC 
Arterial blood gases 
PaO, (kPa) 
PaCO, (kPa) 
Sleep and exercise SaO,% 
Pre-sleep 
Mean sleep 
Minimum sleep 
Sleep fall 
Pre-exercise 
Mean exercise 
Minimum exercise 
Exercise fall 
Exercise duration (s) 
66.3(5.1) 67.7(4.0) 651(50) n.s. 
23.4(1.5) 23.4(1.3) 23.4(1.7) n.s. 
31.3(11.9) 37,4(13.2) 252(6.2) co.01 
446(10.6) 45.5(17.0) 44(12.3) ns. 
86(1.0) 88(0.9) 84(1.1) n.s. 
6.0(0.9) 5.3(0.6) 6.6(0.4) <O.OOl 
92(3.1) 93(2.9) 92(3,2) n.s. 
91(4.3) 92(3.0) 89(4,7) co.05 
79(10.5) 85(58) 74(13.4) co.05 
13(10.5) 8(55) 17(12.2) co.05 
92(4.1) 93(2.5) 91(5.1) n.s. 
91(3.9) 92.4(2.4) 89.7(4.6) co.1 
88(4,9) 90(3.1) 85(5.1) co.01 
4(3.7) 3(3.3) 6(3.4) co.02 
132(104) 142(93) 123(114) n.s. 
Data are means (SD). Abbreviations: BMI, body mass index; SaO,z%, oxyhaemoglobin 
saturation; Sleep fall, maximum fall in SaO, from pre-sleep value; Exercise fall, maximum fall 
in SaO, during exercise from resting pre-exercise value. *P value compares the normocapnic 
and hypercapnic groups. 
was brief [mean 132( 104) s], patients were encouraged 
to exercise to exhaustion, and all discontinued exer- 
cise because of severe dyspnoea. Two patients had a 
rise in SaO, on exercise, while it was unchanged in 
two others. These four patients who did not desatu- 
rate during exercise had a mean nocturnal fall in 
SaO, of 7.8% (range 412%) and furthermore, sev- 
eral patients who had minimal falls in SaO, during 
exercise had quite marked drops in nocturnal SaO, 
(e.g. 4% on exercise, 24% during sleep). The maximal 
heart rate on exercise was 138( 15) beats min - ‘. 
Among the group of 25 patients, 12 had PaCO, 
I 6 kPa (normocapnic, Group A) and 13 had PaCO, 
~6 kPa (hypercapnic, Group B). The findings during 
sleep and exercise among these two groups of 
patients are outlined in Table 1. Fortuitously, these 
two groups had similar daytime PaO,, in addition to 
similar pre-sleep and pre-exercise SaO,, although 
Group B had more severe airways obstruction. 
Despite similar awake PaO, and SaO, however, 
patients with hypercapnia desaturated significantly 
more than those with normal PaCO, during both 
sleep (PcO.05) and exercise (PcO.02). Seven of 12 
Group A patients maintained their SaO, at baseline 
levels during sleep, while only two of Group B did so 
(PcO.01 by two-tailed Fisher’s Exact Test). Further- 
more, 12 of 13 Group B patients had a minimum 
nocturnal SaO, of 85% or less, while only five out of 
12 Group A patients did so (PzO.01 by two-tailed 
Fisher’s Exact Test). The duration of exercise and 
maximum heart rate during exercise was similar in 
the two groups (Table 1). 
We separately examined the data for a subgroup 
of six patients who had more severe daytime 
hypoxaemia [PaO, c8.0 kPa, mean PaO,= 
7.2(0.27)kPa, mean PaCO, =6.3( 1 .O)kPa]. The find- 
ings in this subgroup with respect to comparisons of 
sleep and exercise desaturation were similar to the 
overall patient group. They had a substantially 
lower minimum SaO, during sleep than exercise 
[76.3(6.2)% vs. 85.2(5.3)%, P<O.Ol]. 
The correlation of SaO, with resting, awake blood 
gases and pulmonary function during both sleep and 
exercise, is outlined in Table 2. Awake PaO, and 
SaO, correlated well with mean nocturnal SaO,, 
similar to several previous reports (4,8-10). However, 
we found a lesser correlation between awake oxygen 
levels, and both minimum nocturnal SaO, and the 
maximum fall in SaO, from awake values. Daytime 
PaCO, was not correlated with any nocturnal SaO, 
variable. Resting awake PaO, and pre-exercise SaO, 
correlated significantly with the mean and the mini- 
mum exercise SaO,, but not with the fall in SaO, 
on exercise. Pulmonary function correlated poorly 
with exercise SaO,. Neither awake PaO, nor FEV, 
correlated significantly with exercise duration. 
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Table 2 Correlation of sleep and exercise SaO, with resting awake variables 
Age Weight FEV, PaO, PaCO, Sa%t 
Sleep 
Mean SaO, -0.37 - 0.55** 0.33 0.54** -0.36 0.69*** 
Minimum SaO, - 0.29 -0.54** 0.38 0.35 -0.35 044* 
Fall in SaO, 0.23 0.48* - 0.40* -0.23 0.34 -0.21 
Exercise 
Mean SaO, 0.07 - 0.33 0.34 0.44* -0.32 0.90*** 
Minimum SaO, - 0.01 - 0.30 0.37 0.45* -0.51** 0.67*** 
Fall in SaO, - 0.01 0.07 - 0.19 -0.07 0.46* -21 
Data are correlation coefficients. SaO,t represents resting awake SaOz either pre-sleep or 
pre-exercise as appropriate. Levels of significance: *P<O.O5, **P<O.Ol, ***P<O.OOl. 
100 
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Pig, I Comparison of the minimum SaO,.during sleep and exercise. 
Nocturnal and exercise desaturation were also 
compared, to see whether exercise desaturation cor- 
related better with nocturnal SaO, than pulmonary 
function tests or daytime blood gases. The mean and 
minimum nocturnal and exercise SaO, were signifi- 
cantly correlated (r=0.51, PcO.05 and r=044, 
PcO.05, respectively; Fig. l), but there was only a 
trend for the fall in exercise SaO, to correlate with 
the fall in nocturnal SaO, (r=0.37, P=n.s.). 
Discussion 
Previous reports have demonstrated a close associ- 
ation between awake PaO, and nocturnal oxygen 
desaturation, and our data broadly agree with these 
findings. However, the present study documents a 
number of novel findings with respect to sleep-related 
hypoxaemia in COPD, namely that (1) oxygen 
desaturation is greater during sleep than during 
maximum exercise, in patients with severe COPD, 
and exercise studies are no better than awake resting 
arterial blood gases in the prediction of nocturnal 
oxygen desaturation, and (2) the presence of hyper- 
capnia increases the likelihood of nocturnal oxygen 
desaturation even when awake PaO, levels are simi- 
lar among normocapnic and hypercapnic patients. 
Previous authors have sought ‘awake variables’ 
that would help in the prediction of nocturnal oxygen 
desaturation (1,5,8-lo), but there are no detailed 
reports which address the relationships of SaO, dur- 
ing sleep and exercise in the same group of patients 
with COPD, although Fletcher and co-workers make 
minor reference to this relationship, in a study of 
pulmonary haemodynamics during sleep and exercise 
in COPD (13). Our data indicate that exercise studies 
are of no greater benefit in predicting the magnitude 
of nocturnal oxygen desaturation than daytime blood 
gases. 
Our data suggest that hypercapnia contributes to 
the development of nocturnal hypoxaemia, indepen- 
dent of awake PaO, levels (Table l), since, fortu- 
itously, our hypercapnic group of COPD patients 
had similar awake PaO, levels to the normocapnic 
group. These findings support the observations of 
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Bradley and co-authors (lo), but, in contrast to these 
authors, we did not find any significant correlation 
between daytime PaCO, and sleep SaO, (Table 2). 
The degree of nocturnal desaturation has previously 
been shown to correlate with the hypercapnic venti- 
latory response (22), suggesting that hypercapnic 
patients have a greater tendency to nocturnal 
hypoventilation. A possible confounding factor, 
however, is the relatively mild degree of hypercapnia 
among the hypercapnic group in the present study 
(Table 1). 
Previous reports have generally shown good cor- 
relation between daytime PaO, or SaO, and mean 
nocturnal SaO, (4,8-lo), but these variables have 
been found to be less accurate in predicting the 
minimum level of nocturnal SaO, (5,9). Our findings 
agree with these previous reports, but also demon- 
strate that the magnitude of sleep desaturation can- 
not be predicted from either awake SaO, or PaO,, 
and also that the magnitude of exercise desaturation 
does not correlate with sleep desaturation. This 
observation agrees with a previous study from this 
department among adult and adolescent patients 
with cystic fibrosis, performed using very similar 
methodology to the present study (21). This particu- 
lar finding should not be surprising, however, since 
the baseline SaO, must inevitably have some influ- 
ence on the absolute levels of SaO, during sleep and 
exercise, and thus these variables are not indepen- 
dent. The magnitude of desaturation from the start- 
ing awake SaO, level is not, however, necessarily 
dependent on the awake level (apart from the 
influence of the oxyhaemoglobin-dissociation curve). 
The duration of major oxygen desaturation during 
sleep tended to be brief. However, all except one of 
our patients desaturated to less than 90% for at least 
5 min, and many patients had substantially greater 
degrees of nocturnal hypoxaemia. Fletcher and 
co-workers (23) have demonstrated that among 
COPD patients with a daytime PaO, >60 mmHg, 
those who have nocturnal desaturation of less than 
85% SaO,, have significantly higher pulmonary 
vascular resistance than those without significant 
nocturnal desaturation, even when the awake PaO, 
levels are similar. These authors have also shown (13) 
that minimum sleep SaO, was a better discriminant 
of increased pulmonary vascular resistance than 
mean sleep SaO,. Our data shows that minimum 
nocturnal SaO, was significantly lower than mini- 
mum exercise SaO, (Table l), suggesting that among 
COPD patients, the greatest challenge to their 
cardiovascular system is at night. 
Overall, the patients were unable to tolerate 
prolonged exercise, which may have been related to 
the fact that they were convalescing from an exacer- 
bation of COPD. However, the patients were encour- 
aged to walk for as long as possible, and all stopped 
the test because of severe dyspnoea or exhaustion. 
Furthermore, the level of exercise achieved would 
almost certainly be greater than that reached during 
normal daily activities. We recognize the possibility 
that patients might have responded differently due to 
encouragement by staff when requested to exercise to 
exhaustion, but feel that these differences would be 
similar in daily life, since one would expect that those 
patients who respond best to encouragement during 
exercise testing would also be likely to push them- 
selves more during daily activities. It is possible that 
other forms of exercise testing, such as a 6 min walk 
might have shown different exercise tolerance. 
We must recognize the possibility that the lack of 
formal sleep staging may have resulted in a failure to 
identify poor sleep quality among some of our 
patients. Thus we are unable to say whether all 
patients achieved REM sleep, which may have led us 
to underestimate the true degree of nocturnal desatu- 
ration among our patients. However, this should not 
detract from the principal findings of our study, 
namely that oxygen desaturation was greater during 
sleep than exercise, and furthermore that significant 
nocturnal oxygen desaturation can be found among 
patients with relatively normal PaO,. 
We must also address the possibility that some 
patients with sleep apnoea syndrome were inadvert- 
ently included in the analysis, thereby exaggerating 
the degree of nocturnal desaturation. However, we 
took great care to prevent this possibility by exclud- 
ing any patients with symptoms or nocturnal tracings 
suggestive of sleep apnoea. Patients with sleep 
apnoea have a typical pattern of repetitive transient 
dips in SaO, during sleep, which differs markedly 
from the pattern of oxygen desaturation during sleep 
among patients with COPD (24). 
We chose to examine patients who were in the 
convalescent phase of an exacerbation of COPD. 
While we recognize that such patients may not have 
reverted fully to their baseline functional status, this 
fact should not influence the comparisons made in 
the present study, since the comparisons between 
awake, sleep and exercise oxygen levels were made 
within a 24 h period. Furthermore, since daytime 
PaO,, sleep SaO, and exercise SaO, are all likely to 
be affected to a similar degree by lack of functional 
stability, the principal findings of the relationships 
between these variables are unlikely to have been 
affected. 
We conclude from our findings that in severe 
COPD, sleep is associated with greater oxygen 
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desaturation than maximum exercise, and evaluation 
of exercise-induced desaturation adds little to the 
knowledge of resting awake PaO, in the prediction of 
nocturnal desaturation. 
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